Calcium channels in the GABAergic presynaptic nerve terminals projecting to meynert neurons of the rat

J Neurochem. 1999 Feb;72(2):800-7. doi: 10.1046/j.1471-4159.1999.0720800.x.

Abstract

Effects of selective Ca2+ channel blockers on GABAergic inhibitory postsynaptic currents (IPSCs) were studied in the acutely dissociated rat nucleus basalis of Meynert (nBM) neurons attached with nerve endings, namely, the "synaptic bouton" preparation, and in the thin slices of nBM, using nystatin perforated and conventional whole-cell patch recording modes, respectively. In the synaptic bouton preparation, nicardipine (3 x 10(-6) M) and omega-conotoxin-MVIIC (3 x 10(-6) M) reduced the frequency of spontaneous postsynaptic currents by 37 and 22%, respectively, whereas omega-conotoxin-GVIA had no effect. After blockade of L- and P/Q-type Ca2+ channels, successive removal of Ca2+ from external solution had no significant effect on the residual spontaneous activities, indicating that N-, R-, and T-type Ca2+ channels are not involved in the spontaneous GABA release. Thapsigargin, but not ryanodine, increased the frequency of spontaneous IPSCs in both the synaptic bouton and slice preparations, suggesting the partial contribution of the intracellular Ca2+ storage site to the spontaneous GABA release. In contrast, omega-conotoxin-GVIA (3 x 10(-6) M) and omega-conotoxin-MVIIC (3 x 10(-6) M) suppressed the evoked IPSCs by 31 and 37%, respectively, but nicardipine produced no significant effect. The residual evoked currents were abolished in Ca2+-free external solution but not in the external solution containing 10(-5) M Ni2+, suggesting the involvement of N-, P/Q-, and R-type Ca2+ channels but not L- and T-type ones in the evoked IPSCs. Neither thapsigargin nor ryanodine had any significant effects on the evoked IPSCs. It was concluded that Ca2+ channel subtypes responsible for spontaneous transmitter release are different from those mediating the transmitter release evoked by nerve stimulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester / pharmacology
  • 6-Cyano-7-nitroquinoxaline-2,3-dione / pharmacology
  • Animals
  • Calcium Channel Agonists / pharmacology
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels / analysis*
  • Cholinergic Fibers / chemistry
  • Electrophysiology
  • Enzyme Inhibitors / pharmacology
  • Excitatory Amino Acid Antagonists / pharmacology
  • Membrane Potentials / drug effects
  • Neural Inhibition / physiology
  • Nicardipine / pharmacology
  • Organ Culture Techniques
  • Peptides / pharmacology
  • Presynaptic Terminals / chemistry*
  • Rats
  • Rats, Wistar
  • Ryanodine / pharmacology
  • Substantia Innominata / chemistry
  • Substantia Innominata / cytology*
  • Tetrodotoxin / pharmacology
  • Thapsigargin / pharmacology
  • gamma-Aminobutyric Acid / physiology*
  • omega-Conotoxin GVIA
  • omega-Conotoxins*

Substances

  • Calcium Channel Agonists
  • Calcium Channel Blockers
  • Calcium Channels
  • Enzyme Inhibitors
  • Excitatory Amino Acid Antagonists
  • Peptides
  • omega-Conotoxins
  • omega-conotoxin-MVIIC
  • Ryanodine
  • Tetrodotoxin
  • gamma-Aminobutyric Acid
  • Thapsigargin
  • 6-Cyano-7-nitroquinoxaline-2,3-dione
  • 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
  • omega-Conotoxin GVIA
  • Nicardipine